Imperial College London Featured PhD Programmes
Heriot-Watt University Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
University of Liverpool Featured PhD Programmes
University of Sheffield Featured PhD Programmes
"medicinal"×
10 miles

Organic Chemistry (medicinal) PhD Projects, Programs & Scholarships

We have 17 Organic Chemistry (medicinal) PhD Projects, Programs & Scholarships

  • "medicinal" ×
  • Organic Chemistry×
  • clear all
Order by 
Showing 1 to 10 of 17
  Medicinal Chemistry - ‘Prion diseases: how to develop therapies for prion diseases’
  Prof S Ward
Application Deadline: 10 June 2019

Funding Type

PhD Type

This research project will be funded through a Scholarship which will be delivered jointly by the Coleg Cymraeg Cenedlaethol and Cardiff University.
  Biomolecular Science and Medicinal Chemistry Division PhD project: Proteases in the ubiquitin system – from molecular mechanisms to the development of novel inhibitors
  Dr I Dreveny
Applications accepted all year round

Funding Type

PhD Type

Ubiquitin is a posttranslational modifier that tags substrate proteins for degradation and regulates virtually all known cellular processes.
  Novel Cyclic Peptides for Biomedical Imaging and Therapeutic Targeting
  Prof M Zanda
Applications accepted all year round

Funding Type

PhD Type

Cyclic Peptides have a wide range of applications as drugs and diagnostics, and have often higher receptor affinity, metabolic stability and better pharmacokinetic properties compared to their linear counterparts, but their synthesis still presents significant challenges.
  Total synthesis of marine polycyclic ether natural products to tackle Alzheimer’s disease
  Dr M Kimber
Application Deadline: 30 September 2019

Funding Type

PhD Type

This project will develop an efficient asymmetric synthesis of marine polycyclic ether natural products.
  Neuropeptide Research - PhD Opportunity at a World Class Institution
  Dr M Muttenthaler, Assoc Prof C Schroeder, Assoc Prof I Vetter
Application Deadline: 4 June 2019

Funding Type

PhD Type

We are seeking talented and highly motivated PhD candidates for the following multidisciplinary project. Neuropeptides are key mediators in many biological functions and understanding their interaction with target proteins is fundamental to unravel the underlying mechanism of diseases.
  Structure based design of novel warheads for use in peptide-drug conjugates
  Dr S Butterworth, Dr A Tirella, Dr D Wiseman
Applications accepted all year round

Funding Type

PhD Type

Chronic Myelomonocytic Leukaemia (CMML) is an orphan disease defined by myeloid dysplasia, myeloproliferation and a malignant expansion of classical monocytes.
  Novel synthetic approaches to antimicrobial natural products and investigations of their bioactivity
  Prof A Malkov
Applications accepted all year round

Funding Type

PhD Type

The aim of the project is to develop new highly effective anti-tubercular agents. Previously, it has been established that terpenes isolated from marine organisms possess a number of important antibacterial properties.
  Small molecule/drug discovery for inhibition of the GEF-H1/RhoA pathway
  Dr M Balda
Application Deadline: 30 May 2019

Funding Type

PhD Type

PhD fellowship available to start Autumn 2019. We offer a full-time PhD Student post for 3 years to develop prototype drugs for treatments of the most common ocular diseases.
  Chemical modulation of cellular redox balance for cancer treatment
  Dr I Romero-Canelon
Applications accepted all year round

Funding Type

PhD Type

Platinum complexes, cisplatin, oxaliplatin and carboplatin, are the most widely used anticancer drugs. However, these DNA-targeting treatments are a low selectivity approach with deleterious consequences and a high incidence of resistance.
  Precious metals in the fight against cancer
  Dr I Romero-Canelon
Applications accepted all year round

Funding Type

PhD Type

Platinum-based complexes, Cisplatin, Oxaliplatin and Carboplatin, are the most widely used chemotherapeutics, nonetheless there is a major unmet clinical need for new treatments that expand the range of treatable cancers and overcome inherent and acquired platinum resistance.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.